UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study

British journal of cancer, 2016-10, Vol.115 (9), p.1140-1146

2016

Link zum Volltext

Verfügbarkeit prüfen

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

The Lancet (British edition), 2021-12, Vol.398 (10316), p.2084-2092

2021

Link zum Volltext

Verfügbarkeit prüfen

Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses

British journal of cancer, 2021-04, Vol.124 (8), p.1361-1365

2021

Link zum Volltext

Verfügbarkeit prüfen

Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study

PLoS medicine, 2014-01, Vol.11 (1), p.e1001585-e1001585

2014

Link zum Volltext

Verfügbarkeit prüfen

Acceleration of cervical cancer diagnosis with human papillomavirus testing below age 30: Observational study

International journal of cancer, 2022-05, Vol.150 (9), p.1412-1421

2022

Link zum Volltext

Verfügbarkeit prüfen

RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16

Journal of comparative effectiveness research, 2024-08, Vol.13 (8), p.e240095

2024

Link zum Volltext

Verfügbarkeit prüfen

Why is target trial emulation not being used in health technology assessment real-world data submissions?

Journal of comparative effectiveness research, 2024-08, Vol.13 (8), p.e240091

2024

Link zum Volltext

Verfügbarkeit prüfen

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?

Journal of medical screening, 2019-03, Vol.26 (1), p.44-49

2019

Link zum Volltext

Verfügbarkeit prüfen

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany

Journal of clinical microbiology, 2015-08, Vol.53 (8), p.2509-2516

2015

Link zum Volltext

Verfügbarkeit prüfen

Survival from Cervical Cancer Diagnosed Aged 20-29 Years by Age at First Invitation to Screening in England: Population-Based Study

Cancers, 2020-07, Vol.12 (8), p.2079

2020

Link zum Volltext

Verfügbarkeit prüfen

The impact of the COVID-19 pandemic on cardiovascular disease prevention and corresponding geographical inequalities in England: interrupted time series analysis

BMC public health, 2023-12, Vol.23 (1), p.2443-2443, Article 2443

2023

Link zum Volltext

Verfügbarkeit prüfen

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15

Journal of comparative effectiveness research, 2024-05, Vol.13 (5), p.e240033-e240033

2024

Link zum Volltext

Verfügbarkeit prüfen

A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions

eLife, 2022-10, Vol.11

2022

Link zum Volltext

Verfügbarkeit prüfen

EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?

Journal of comparative effectiveness research, 2024-06, Vol.13 (6), p.e240052-e240052

2024

Link zum Volltext

Verfügbarkeit prüfen

Technological advances: Have they improved standards? Review of outcomes from the Welsh cervical screening programme

Journal of medical screening, 2021-06, Vol.28 (2), p.80-87

Castanon, Alejandra

2021

Link zum Volltext

Verfügbarkeit prüfen

HPV vaccination and cervical cancer screening – Authors' reply

The Lancet (British edition), 2022-05, Vol.399 (10339), p.1940-1940

2022

Link zum Volltext

Verfügbarkeit prüfen

Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern?

Preventive medicine, 2018-02, Vol.107, p.21-28

2018

Link zum Volltext

Verfügbarkeit prüfen

Evidence of HPV vaccination efficacy comes from more than clinical trials

Vaccine, 2020-07, Vol.38 (35), p.5569-5571

2020

Link zum Volltext

Verfügbarkeit prüfen

OP338 Involving Patients In Research: Early Consultation Of Women To Improve Study Design And Investigate Trial Acceptability

International journal of technology assessment in health care, 2021-12, Vol.37 (S1), p.14-14

2021

Link zum Volltext

Verfügbarkeit prüfen

Is the recent increase in cervical cancer in women aged 20–24years in England a cause for concern?

Preventive medicine, 2018-02, Vol.107, p.21-28

2018

Link zum Volltext

Verfügbarkeit prüfen

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?

International journal of cancer, 2016-09, Vol.139 (5), p.1040-1045

2016

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

BMJ (Online), 2009-08, Vol.339 (7716), p.328-328

International edition, 2009

Link zum Volltext

Verfügbarkeit prüfen

Cone depth increases risk of adverse obstetric outcomes following treatment for cervical preinvasive disease

Evidence-based medicine (English ed.), 2017-03, Vol.22 (1), p.37

Castanon, Alejandra

2017

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 disruption to cervical cancer screening in England

Journal of medical screening, 2022-09, Vol.29 (3), p.203

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study

Preventive medicine, 2021-08, Vol.149, p.106625-106625, Article 106625

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(85)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(52)
Humans
(47)
Female
(42)
Uterine Cervical Neoplasms - Diagnosis
(26)
Cervical Cancer
(25)
Adult
(22)
Medical Screening
(18)
Middle Aged
(18)
Public, Environmental & Occupational Health
(17)
Womens Health
(16)
Early Detection Of Cancer
(15)
Human Papillomavirus
(14)
Uterine Cervical Neoplasms - Epidemiology
(14)
Oncology
(13)
Uterine Cervical Neoplasms - Prevention & Control
(13)
General & Internal Medicine
(12)
Mass Screening
(12)
Medicine, General & Internal
(12)
Papillomavirus Infections - Diagnosis
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses

Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study

Acceleration of cervical cancer diagnosis with human papillomavirus testing below age 30: Observational study

RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16

Why is target trial emulation not being used in health technology assessment real-world data submissions?

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany

Survival from Cervical Cancer Diagnosed Aged 20-29 Years by Age at First Invitation to Screening in England: Population-Based Study

The impact of the COVID-19 pandemic on cardiovascular disease prevention and corresponding geographical inequalities in England: interrupted time series analysis

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15

A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions

EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?

Technological advances: Have they improved standards? Review of outcomes from the Welsh cervical screening programme

HPV vaccination and cervical cancer screening – Authors' reply

Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern?

Evidence of HPV vaccination efficacy comes from more than clinical trials

OP338 Involving Patients In Research: Early Consultation Of Women To Improve Study Design And Investigate Trial Acceptability

Is the recent increase in cervical cancer in women aged 20–24years in England a cause for concern?

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

Cone depth increases risk of adverse obstetric outcomes following treatment for cervical preinvasive disease

COVID-19 disruption to cervical cancer screening in England

Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study

Suchergebnisse filtern